COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu
Trial record 80 of 2994 for:    Neoplasms | Neuroendocrine Tumors

An Imaging Study of 64Cu-SARTATE Using Positron Emission Tomography in Patients With Neuroendocrine Tumours

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04440956
Recruitment Status : Completed
First Posted : June 22, 2020
Last Update Posted : June 22, 2020
Information provided by (Responsible Party):
Clarity Pharmaceuticals Ltd

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : February 25, 2016
Actual Study Completion Date : February 25, 2016